search
Back to results

Study Designed to Clinically Evaluate Sinus Wash Device Prototypes

Primary Purpose

Sinusitis, Maxillary Sinusitis

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
SinuSafe Medical Device for Maxillary Sinus
Sponsored by
SinuSafe Medical LTD
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sinusitis focused on measuring sinus wash, sinus lavage, Sinusitis

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Male or female, 18-65 years of age.
  2. Signs and symptoms of acute exacerbation during chronic maxillary sinusitis.
  3. Pain higher than 5 in VAS of 0-10.
  4. Able to understand and provide written informed consent.

Exclusion Criteria:

  1. Patients who have a clinically significant or unstable medical or surgical condition that may preclude safe and complete study participation as determined by medical history based on the opinion of the investigator.
  2. Extensive sinonasal polyps that may interfere with the treatment procedure.
  3. Previous sinonasal surgery.
  4. Acute exacerbation of sinusitis in the frontal or sphenoid sinuses.
  5. Sinonasal osteoneogenesis.
  6. Cystic fibrosis.
  7. Sinonasal tumors or obstructive lesions.
  8. Presence of features consistent with sinus fungal disease on CT or physical examination.
  9. History of facial trauma that distorted the sinus anatomy.
  10. Ciliary dysfunction.
  11. History of insulin dependent diabetes.
  12. Not able to stop anti-coagulant (e.g., warfarin) until the International Normalized Ratio (INR) is below 1.5.
  13. Not able to stop anti-platelet (e.g., clopidogrel, aspirin, etc.) for at least 14 days prior to study procedure.
  14. Not able to stop any non-steroidal anti-inflammatory medications and homeopathic medications for at least 14 days prior to the study procedure.
  15. Pregnancy.
  16. Psychiatric disease.
  17. Currently participating in other drug or device studies.
  18. Investigator's opinion that the subject should not be in the study such as any conditions that could compromise the wellbeing of the patient or integrity of the study or prevent the patient from meeting or performing study requirements.
  19. Patient is not capable of following the study schedule for any reason.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Sinus irrigation

    Arm Description

    Sinus irrigation intervention

    Outcomes

    Primary Outcome Measures

    Adverse events
    Presence of adverse events

    Secondary Outcome Measures

    Mucosal damage visual inspection
    Visual inspection of sinus mucosa with the endoscope looking for mucosal damage.
    Syringe visual inspection
    Visual inspection of the aspirated liquids looking for bleeding. Excess nasal bleeding shall be defined as a doctor decision to use sinus or nasal packing.
    Pain during procedure
    Pain during procedure with the VAS pain scale
    Usability & Tolerability Questionnaire
    Usability & Tolerability Questionnaire
    Mucus leftovers visual inspection
    Visual inspection of sinus mucosa with the endoscope looking for mucus leftovers
    Mucus aspiration into the syringe
    Mucus aspiration into the syringe (yes/ no and time)
    Pain relief
    Pain relief in the post-treatment VAS pain scale
    Time measurements of cannula insertion.
    Time measurements of cannula insertion
    Time measurements of irrigation and aspiration
    Time measurements of irrigation and aspiration
    SNOT 20 questionnaire
    SNOT 20 questionnaire (Hebrew version) to evaluate the patient's severity level before the treatment

    Full Information

    First Posted
    September 13, 2016
    Last Updated
    October 10, 2016
    Sponsor
    SinuSafe Medical LTD
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02931604
    Brief Title
    Study Designed to Clinically Evaluate Sinus Wash Device Prototypes
    Official Title
    Pilot Study Designed to Clinically Evaluate Sinus Wash Device Prototypes in Patients With Sinusitis During Endoscopic Sinus Surgery (ESS) and in the Hospital Outpatient
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2016
    Overall Recruitment Status
    Unknown status
    Study Start Date
    January 2017 (undefined)
    Primary Completion Date
    November 2019 (Anticipated)
    Study Completion Date
    January 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    SinuSafe Medical LTD

    4. Oversight

    5. Study Description

    Brief Summary
    The purpose of this study is to clinically evaluate sinus wash device prototypes in patients with sinusitis during Endoscopic Sinus Surgery (ESS) and in the hospital outpatient

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Sinusitis, Maxillary Sinusitis
    Keywords
    sinus wash, sinus lavage, Sinusitis

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    50 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Sinus irrigation
    Arm Type
    Experimental
    Arm Description
    Sinus irrigation intervention
    Intervention Type
    Device
    Intervention Name(s)
    SinuSafe Medical Device for Maxillary Sinus
    Intervention Description
    Sinus lavage via the natural sinus ostium, without ostial dilation.
    Primary Outcome Measure Information:
    Title
    Adverse events
    Description
    Presence of adverse events
    Time Frame
    Within day 1
    Secondary Outcome Measure Information:
    Title
    Mucosal damage visual inspection
    Description
    Visual inspection of sinus mucosa with the endoscope looking for mucosal damage.
    Time Frame
    Within 1 hour
    Title
    Syringe visual inspection
    Description
    Visual inspection of the aspirated liquids looking for bleeding. Excess nasal bleeding shall be defined as a doctor decision to use sinus or nasal packing.
    Time Frame
    Within 1 hour
    Title
    Pain during procedure
    Description
    Pain during procedure with the VAS pain scale
    Time Frame
    Within 1 hour
    Title
    Usability & Tolerability Questionnaire
    Description
    Usability & Tolerability Questionnaire
    Time Frame
    Within 1 hour
    Title
    Mucus leftovers visual inspection
    Description
    Visual inspection of sinus mucosa with the endoscope looking for mucus leftovers
    Time Frame
    Within 1 hour
    Title
    Mucus aspiration into the syringe
    Description
    Mucus aspiration into the syringe (yes/ no and time)
    Time Frame
    Within 1 hour
    Title
    Pain relief
    Description
    Pain relief in the post-treatment VAS pain scale
    Time Frame
    Within 1 hour
    Title
    Time measurements of cannula insertion.
    Description
    Time measurements of cannula insertion
    Time Frame
    Within 1 hour
    Title
    Time measurements of irrigation and aspiration
    Description
    Time measurements of irrigation and aspiration
    Time Frame
    Within 1 hour
    Title
    SNOT 20 questionnaire
    Description
    SNOT 20 questionnaire (Hebrew version) to evaluate the patient's severity level before the treatment
    Time Frame
    Within 1 hour

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Male or female, 18-65 years of age. Signs and symptoms of acute exacerbation during chronic maxillary sinusitis. Pain higher than 5 in VAS of 0-10. Able to understand and provide written informed consent. Exclusion Criteria: Patients who have a clinically significant or unstable medical or surgical condition that may preclude safe and complete study participation as determined by medical history based on the opinion of the investigator. Extensive sinonasal polyps that may interfere with the treatment procedure. Previous sinonasal surgery. Acute exacerbation of sinusitis in the frontal or sphenoid sinuses. Sinonasal osteoneogenesis. Cystic fibrosis. Sinonasal tumors or obstructive lesions. Presence of features consistent with sinus fungal disease on CT or physical examination. History of facial trauma that distorted the sinus anatomy. Ciliary dysfunction. History of insulin dependent diabetes. Not able to stop anti-coagulant (e.g., warfarin) until the International Normalized Ratio (INR) is below 1.5. Not able to stop anti-platelet (e.g., clopidogrel, aspirin, etc.) for at least 14 days prior to study procedure. Not able to stop any non-steroidal anti-inflammatory medications and homeopathic medications for at least 14 days prior to the study procedure. Pregnancy. Psychiatric disease. Currently participating in other drug or device studies. Investigator's opinion that the subject should not be in the study such as any conditions that could compromise the wellbeing of the patient or integrity of the study or prevent the patient from meeting or performing study requirements. Patient is not capable of following the study schedule for any reason.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Avinoam Gemer
    Phone
    972-544-858822
    Email
    avinoamgemer@gmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Itzhak Braverman, Professor
    Organizational Affiliation
    Hillel Yaffe Medical Center
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Study Designed to Clinically Evaluate Sinus Wash Device Prototypes

    We'll reach out to this number within 24 hrs